Catheter-related bloodstream infection (CRBSI), a severe type of hospital-acquired infection, is commonly associated with the use of central venous catheters (CVCs). With growing concerns around antibiotic resistance and multidrug-resistant organisms (MDROs), the correlation between MDROs and CRBSI is gaining heightened scrutiny. Moreover, given the scarcity of literature on CRBSI in relation to MDROs, this comprehensive…
The Catheter Related Bloodstream Infection (CRBSI) market is projected to experience substantial growth, reaching an estimated value of around $2.5 billion by 2033, up from $1.5 billion in 2023. This and rise represents a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2024 – 2033. The escalating occurrence of CRBSIs, primarily…